610 Medizin und Gesundheit
Refine
Year of publication
Document Type
- Article (6513)
- Doctoral Thesis (2102)
- Preprint (313)
- Part of Periodical (247)
- Conference Proceeding (218)
- Contribution to a Periodical (199)
- Book (176)
- Review (59)
- Part of a Book (39)
- Working Paper (17)
Language
- English (6658)
- German (3199)
- Latin (26)
- mis (13)
- Multiple languages (13)
- French (11)
- Spanish (2)
- Portuguese (1)
- Romanian (1)
- Russian (1)
Keywords
- inflammation (106)
- COVID-19 (79)
- SARS-CoV-2 (61)
- cancer (47)
- Inflammation (43)
- apoptosis (43)
- glioblastoma (38)
- breast cancer (35)
- autophagy (33)
- Cancer (31)
Institute
- Medizin (7963)
- Pharmazie (300)
- Präsidium (283)
- Biowissenschaften (277)
- Biochemie, Chemie und Pharmazie (276)
- Biochemie und Chemie (222)
- Frankfurt Institute for Advanced Studies (FIAS) (160)
- Georg-Speyer-Haus (138)
- Sportwissenschaften (137)
- Psychologie (100)
Highlights
• HHT ameliorates peritonitis-related inflammatory processes in vivo.
• HT/HHT lower inflammatory activation of ECs (leukocyte adhesion, CAM expression).
• HHT reduces VCAM-1 mRNA expression through impairing IRF-1 signaling.
• HHT affects ICAM-1/E-selectin expression by reducing de novo protein biosynthesis.
Abstract
The plant alkaloid homoharringtonine (HHT) is a Food and Drug Administration (FDA)-approved drug for the treatment of hematologic malignancies. In addition to its well-established antitumor activity, accumulating evidence attributes anti-inflammatory effects to HHT, which have mainly been studied in leukocytes to date. However, a potential influence of HHT on inflammatory activation processes in endothelial cells, which are a key feature of inflammation and a prerequisite for the leukocyte-endothelial cell interaction and leukocyte extravasation, remains poorly understood. In this study, the anti-inflammatory potential of HHT and its derivative harringtonine (HT) on the TNF-induced leukocyte-endothelial cell interaction was assessed, and the underlying mechanistic basis of these effects was elucidated. HHT affected inflammation in vivo in a murine peritonitis model by reducing leukocyte infiltration and proinflammatory cytokine expression as well as ameliorating abdominal pain behavior. In vitro, HT and HHT impaired the leukocyte-endothelial cell interaction by decreasing the expression of the endothelial cell adhesion molecules intracellular adhesion molecule −1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). This effect was mediated by a bipartite mechanism. While HHT did not affect the prominent TNF-induced pro-inflammatory NF-ĸB signaling cascade, the compound downregulated the VCAM1 mRNA expression in an IRF-1-dependent manner and diminished active ICAM1 mRNA translation as determined by polysome profiling. This study highlights HHT as an anti-inflammatory compound that efficiently hampers the leukocyte-endothelial cell interaction by targeting endothelial activation processes.
Protein associated with Myc (PAM) is a giant E3 ubiquitin ligase of 510 kDa. Although the role of PAM during neuronal development is well established, very little is known about its function in the regulation of synaptic strength. Here we used multiepitope ligand cartography (MELC) to study protein network profiles associated with PAM during the modulation of synaptic strength. MELC is a novel imaging technology that utilizes biomathematical tools to describe protein networks after consecutive immunohistochemical visualization of up to 100 proteins on the same sample. As an in vivo model to modulate synaptic strength we used the formalin test, a common model for acute and inflammatory pain. MELC analysis was performed with 37 different antibodies or fluorescence tags on spinal cord slices and led to the identification of 1390 PAM-related motifs that distinguish untreated and formalin-treated spinal cords. The majority of these motifs related to ubiquitin-dependent processes and/or the actin cytoskeleton. We detected an intermittent colocalization of PAM and ubiquitin with TSC2, a known substrate of PAM, and the glutamate receptors mGluR5 and GLUR1. Importantly these complexes were detected exclusively in the presence of F-actin. A direct PAM/F-actin interaction was confirmed by colocalization and cosedimentation. The binding of PAM toward F-actin varied strongly between the PAM splice forms found in rat spinal cords. PAM did not ubiquitylate actin or alter actin polymerization and depolymerization. However, F-actin decreased the ubiquitin ligase activity of purified PAM. Because PAM activation is known to involve its translocation, the binding of PAM to F-actin may serve to control its subcellular localization as well as its activity. Taken together we show that defining protein network profiles by topological proteomics analysis is a useful tool to identify previously unknown protein/protein interactions that underlie synaptic processes.
IL-38 is an IL-1 family receptor antagonist with an emerging role in chronic inflammatory diseases. IL-38 expression has been mainly observed not only in epithelia, but also in cells of the immune system, including macrophages and B cells. Given the association of both IL-38 and B cells with chronic inflammation, we explored if IL-38 affects B cell biology. IL-38-deficient mice showed higher amounts of plasma cells (PC) in lymphoid organs but, conversely, lower levels of plasmatic antibody titers. Exploring underlying mechanisms in human B cells revealed that exogenously added IL-38 did not significantly affect early B cell activation or differentiation into plasma cells, even though IL-38 suppressed upregulation of CD38. Instead, IL-38 mRNA expression was transiently upregulated during the differentiation of human B cells to plasma cells in vitro, and knocking down IL-38 during early B cell differentiation increased plasma cell generation, while reducing antibody production, thus reproducing the murine phenotype. Although this endogenous role of IL-38 in B cell differentiation and antibody production did not align with an immunosuppressive function, autoantibody production induced in mice by repeated IL-18 injections was enhanced in an IL-38-deficient background. Taken together, our data suggest that cell-intrinsic IL-38 promotes antibody production at baseline but suppresses the production of autoantibodies in an inflammatory context, which may partially explain its protective role during chronic inflammation.
The importance of biologically active lipid mediators, such as prostanoids, leukotrienes, and specialized pro-resolving mediators, in the regulation of inflammation is well established. While the relevance of cholesterol in the context of atherosclerosis is also widely accepted, the role of cholesterol and its biosynthetic precursors on inflammatory processes is less comprehensively described. In the present mini-review, we summarize the current understanding of the inflammation-regulatory properties of cholesterol and relevant biosynthetic intermediates taking into account the implications of different subcellular distributions. Finally, we discuss the inflammation-regulatory effect of cholesterol homeostasis in the context of SARS-CoV-2 infections.
Introduction: Cardiac arrest in a modern intensive care unit (ICU) is associated with poor outcome although optimal resources are present at all times. Data on cardiac arrest (CA) of the increasing cohort of patients with veno-venous-extracorporeal membrane oxygenation (VV-ECMO) are not available. Due to the highly invasive nature of this procedure, other incidences and causes of cardiac arrest are expected when compared to the ICU population without ECMO. This study focuses on cardiac arrest under VV-ECMO treatment.
Methods: Retrospective single-center observational study including all VV-ECMO patients from 1st January 2019 until 31st March 2022. Primary focus of this study was number and causes for CA during VV-ECMO treatment. Secondary endpoints were treatment procedure, complications and outcome.
Results: 140 patients were treated with VV-ECMO in the study period. Of those, 23 patients had 29 CA with need for cardiopulmonary resuscitation (CPR) during VV-ECMO treatment. Nearly half of all CA (48%; n = 14) occurred during medical procedures and 21% (n = 6) were device related. Pulseless electric activity (PEA) was the most common rhythm upon CPR initiation (72%). ROSC was achieved in 86%, two CA (6.9%) resulted in extracorporeal CPR. Survival to hospital discharge was 13% following CPR.
Conclusion: CA occurs in over 15% of all patients treated with a VV-ECMO. Medical procedures during VV-ECMO are associated with a high risk of CA and should be planned with care. Also, the rate of ROSC was very high, only a small number of patients survived the overall VV-ECMO treatment course.
NADPH oxidases produce reactive oxygen species that differ in localization, type and concentration. Within the Nox family only Nox4 produces H2O2 which can directly oxidize cysteine residues. With this post-translational modification, activity, stability, localization and protein-protein interactions of the affected protein is altered. Nox4 controls differentiation, cellular homeostasis and prevents inflammation. Therefore, is likely that epigenetic mechanisms contribute to the effects of Nox4. One group of epigenetic modifiers are class IIa histone deacetylases (HDACs). We hypothesize that Nox4-derived H2O2 oxidizes HDACs and analyzed whether HDACs can be differentially oxidized by Nox4. As an artificial system, we utilized HEK293 cells, overexpressing Nox4 in a tetracycline-inducible manner. HDAC4 was oxidized upon Nox4 overexpression. Additionally, Nox4 overexpression increased HDAC4 phosphorylation on Ser632. H2O2 disrupted HDAC4/Mef2A complex, which de-represses Mef2A. In endothelial cells such as HUVECs and HMECs, overexpression of HDAC4 significantly reduced tube formation. Overexpression of a redox insensitive HDAC4 had no effect on endothelial tube formation. Treatment with H2O2, induction of Nox4 expression by treatment of the cells with TGFβ and co-overexpression of Nox4 not only induced phosphorylation of HDAC4, but also restored the repressive effect of HDAC4 for tube formation, while overexpression of a redox dead mutant of Nox4 did not.
Rationale: Nox4 is a constitutively active NADPH oxidase that constantly produces low levels of H2O2. Thereby, Nox4 contributes to cell homeostasis and long-term processes, such as differentiation. The high expression of Nox4 seen in endothelial cells contrasts with the low abundance of Nox4 in stem cells, which are accordingly characterized by low levels of H2O2. We hypothesize that Nox4 is a major contributor to endothelial differentiation, is induced during the process of differentiation, and facilitates homeostasis of the resulting endothelial cells.
Objective: To determine the role of No×4 in differentiation of murine inducible pluripotent stem cells (miPSC) into endothelial cells (ECs).
Methods and results: miPSC, generated from mouse embryonic wildtype (WT) and Nox4−/− fibroblasts, were differentiated into endothelial cells (miPSC-EC) by stimulation with BMP4 and VEGF. During this process, Nox4 expression increased and knockout of Nox4 prolonged the abundance of pluripotency markers, while expression of endothelial markers was delayed in differentiating Nox4-depleted iPSCs. Eventually, angiogenic capacity of iPSC-ECs is reduced in Nox4 deficient cells, indicating that an absence of Nox4 diminishes stability of the reached phenotype. As an underlying mechanism, we identified JmjD3 as a redox target of Nox4. iPSC-ECs lacking Nox4 display a lower nuclear abundance of the histone demethylase JmjD3, resulting in an increased triple methylation of histone 3 (H3K27me3), which serves as a repressive mark for several genes involved in differentiation.
Conclusions: Nox4 promotes differentiation of miPSCs into ECs by oxidation of JmjD3 and subsequent demethylation of H3K27me3, which forced endothelial differentiation and stability.
Bacterial biofilms are polymicrobial aggregates embedded in a self-produced matrix, which consists of extracellular polymeric substances (EPS). In a clinical context, bacterial biofilms are related to the development of chronic infections. Notably, their unique properties confer persistence in host niches despite antimicrobial treatment and the host immune response, where their distinct virulence exacerbates disease progression. In vitro models for bacterial biofilms have been developed. Simple models typically provide artificial growth environments, resulting in biofilm development diverging from in vivo biofilms. Consequently, sophisticated models incorporate growth conditions mimicking the environment of chronic infections. Still, they lack host cells, as the pathogenic bacteria cause cytotoxic effects during biofilm formation. In this context, electrospinning represents a promising approach, due to the ability to design nanofibrous scaffolds that closely mimic biological matrices, while maintaining mechanical strength for non-destructive handling in in vitro experiments.
The objective of this thesis was to develop an in vitro biofilm model for chronic wound infections based on electrospun scaffolds, offering high clinical relevance through its close representation of in vivo conditions, the capacity to explore host-biofilm interfaces, and the incorporation of multiple bacterial species within a single biofilm.
Three-dimensional electrospun scaffolds of cellulose acetate (CA) and gelatin were fabricated as scaffolds for biofilm development. The scaffolds were designed to possess composition and physicochemical properties similar to native biofilm microenvironments. Furthermore, high mechanical strength was required to enable the transfer of mature biofilms. The CA-based scaffolds, alone and in combination with gelatin, fulfilled the necessary criteria for physicochemical properties. Gelatin fiber scaffolds were limited due to rapid dissolution in aqueous environments. P. aeruginosa colonization of CA scaffolds did not result in three-dimensional model systems. In contrast, fiber scaffolds of CA and gelatin promoted bacterial distribution throughout their entire dimensions and enabled matrix production. Along with the formation of aggregates and a dense biofilm morphology, this confirmed their maturation. Their high antibiotic tolerance demonstrated the functional properties of mature biofilms. Subsequently, the high mechanical strength of the biofilm models on blend scaffolds enabled the transfer of mature biofilms to ex vivo human skin wounds, imitating a chronic state of wound infection. The novel biofilm model based on nanofibrous scaffolds addressed the major limitations of existing biofilm models by mimicking the native microenvironment of infectious biofilms and facilitating the examination of biofilm-host interfaces.
In the next step, the developed biofilm model system was used to evaluate host biofilm interactions. For this study, in vitro and ex vivo models of human skin wounds were infected with pre-cultivated biofilms of P. aeruginosa. Regarding the structural characterization of biofilm infected wound models, all models enabled biofilm growth in close contact to the wound bed, creating ideal conditions for biofilm host interactions. In the case of viable wound models, an active immune response was demonstrated with cytokine gene expression patterns consistent with in vivo observations. Furthermore, the tissue viability was found to impact bacterial colonization behavior in the wound bed. These observations underscored the relevance of using viable models for studying direct biofilm-host-interactions. The new biofilm model, combined with human wound models of various complexities, demonstrated its applicability across a spectrum of research fields, from basic investigations to translational approaches.
Biofilms in persistent wound infections typically exhibit a polymicrobial nature. Previous investigations have largely concentrated on single species due to the challenges of co-cultivating biofilms of multiple pathogens in vitro. P. aeruginosa and S. aureus were selected to create mono and dual-species biofilms. P. aeruginosa mono-species biofilms and dual-species biofilms exhibited rapid biofilm development. In contrast, the development of S. aureus biofilms was delayed. Initially, the presence of P. aeruginosa stimulated the adhesion of S. aureus in the dual-species biofilms. However, P. aeruginosa became increasingly dominant, revealing both cooperative and competitive interactions. In dual-species biofilms, both species existed in close proximity, essential for interbacterial interactions. All models exhibited high tolerance to antibiotic treatment. The biofilm matrix acting as a penetration barrier was demonstrated as a major factor. Constituents of P. aeruginosa mono-species and dual-species biofilms impaired wound healing by stimulating host
immune responses and reducing cell viability. In contrast, S. aureus biofilms appeared to exhibit proliferative effects with no impairment of wound healing. The biofilm model facilitated the co-cultivation of multiple species in one biofilm, underscoring its similarity to the in vivo environment.
Redox-active mediators are now appreciated as powerful molecules to regulate cellular dynamics such as viability, proliferation, migration, cell contraction, and relaxation, as well as gene expression under physiological and pathophysiological conditions. These molecules include the various reactive oxygen species (ROS), and the gasotransmitters nitric oxide (NO∙), carbon monoxide (CO), and hydrogen sulfide (H2S). For each of these molecules, direct targets have been identified which transmit the signal from the cellular redox state to a cellular response. Besides these redox mediators, various sphingolipid species have turned out as highly bioactive with strong signalling potential. Recent data suggest that there is a cross-regulation existing between the redox mediators and sphingolipid molecules that have a fundamental impact on a cell’s fate and organ function. This review will summarize the effects of the different redox-active mediators on sphingolipid signalling and metabolism, and the impact of this cross-talk on pathophysiological processes. The relevance of therapeutic approaches will be highlighted.